Compounds > moxisylyte
Page last updated: 2024-10-31

moxisylyte and Spasm

moxisylyte has been researched along with Spasm in 3 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Spasm: An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mai, J1
Yuill, GM1
Neary, D1
White, C1
Richens, A1

Trials

2 trials available for moxisylyte and Spasm

ArticleYear
Depression of spasticity by alpha-adrenergic blockade.
    Acta neurologica Scandinavica, 1978, Volume: 57, Issue:1

    Topics: Administration, Oral; Clinical Trials as Topic; Depression, Chemical; Drug Evaluation; Humans; Injec

1978
Letter: Thymoxamine and spasticity.
    Lancet (London, England), 1974, Volume: 1, Issue:7859

    Topics: Administration, Oral; Clinical Trials as Topic; Diazepam; Humans; Injections, Intravenous; Moxisylyt

1974

Other Studies

1 other study available for moxisylyte and Spasm

ArticleYear
Letter: Thymoxamine ineffective against spasticity.
    Lancet (London, England), 1973, Dec-29, Volume: 2, Issue:7844

    Topics: Administration, Oral; Drug Evaluation; Humans; Moxisylyte; Multiple Sclerosis; Myotonia; Spasm; Spon

1973